Investigating long-term effects of COVID-19 on male and female reproductive health

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the long-term effects of COVID-19 on andrological, reproductive, and sexual functions in patients who have recovered from the virus. It will assess potential damage to the hypothalamic-pituitary-testicular hormonal axis in male patients, as well as the prevalence of olfactory dysfunction in both male and female patients. The study will involve detailed assessments of sexual function, reproductive health, and olfactory capabilities, correlating these findings with the severity of the initial COVID-19 infection. Participants will be evaluated at discharge from the infectious phase and monitored for any lasting complications.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients of both sexes recovered from SARS-CoV-2 infection (two negative nasopharyngeal swabs, negative IgM and positive anti SARS-CoV-2 IgG);
* Aged over 18 years of age;
* Ability to understand protocol procedures

Exclusion Criteria:

* Any psychological/psychiatric/other medical conditions compromising the understanding of the nature and purpose of the study, and of its possible consequences
* Uncooperative attitude of the patient

Where it's running

• Federico II University of Naples
  Naples, Italy, Italy Recruiting

Study contacts

• Principal investigator: Rosario Pivonello, Prof. — Federico II University
• Study coordinator: Rosario Pivonello, Prof.
• Email: rosario.pivonello@unina.it
• Phone: 3317328474

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Anktiva for treating Long COVID symptoms

  This will test whether Anktiva helps adults aged 18–69 who had confirmed COVID-19 and now have persistent or worsened Long COVID symptoms.

  Recruiting Phase 2 ImmunityBio, Inc. · El Segundo, California · NCT07123727

• Low-dose sirolimus for adults with Long COVID (PASC)

  This trial will test whether low-dose sirolimus can reduce symptoms in adults who have had Long COVID for at least six months.

  Recruiting Phase 3 Icahn School of Medicine at Mount Sinai · New York, New York · NCT06960928

• Online treatment for emotional disorders in adults with long COVID-19

  This study is testing if an online treatment for emotional issues can help adults with long COVID-19 feel better compared to regular care.

  Recruiting Instituto de Investigación Sanitaria Aragón · Zaragoza, Zaragoza and 1 other locations · NCT06928480

• Investigating neurological complications of long COVID in children and adolescents

  This study is trying to understand how long COVID affects the brains of children and teens aged 6 to 16 by looking at their symptoms and brain activity after they've had the virus.

  Recruiting Azienda Ospedaliero, Universitaria Pisana · Pisa, PI · NCT06876948

• Rehabilitation program to reduce fatigue after COVID-19

  This study is testing a new rehabilitation program called COVIDEx to see if it can help people with Long COVID feel less tired compared to standard care.

  Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT06156176

• Investigating long-term effects of COVID-19 recovery

  This study is trying to see what long-term health problems people might have after recovering from COVID-19.

  Recruiting Federico II University · Naples · NCT05293366

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.